Install
Ajanta Pharma to hold 47th annual general meeting on July 16 Indian Pharma Post Get the latest News & Research on Pharma industry, Viewpoints, Events, Videos, statistics, indianpharmapost.com
- 189articles · 30d
- 8+ hour agolatest article
- Aug 14, 2026earliest in window
- 89%with images
- 245avg words
- Medical 139
- Health & Wellness 102
- Economy, Business & Finance 81
- Health 75
- Business & Industrial 65
- Finance & Business 33
- Science & Technology 21
- News 15
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Indian Pharmacopoeia Commission organizes national conference on quality and safety of biosimilars
10+ hour, 59+ min ago (95+ words) The Indian Pharmacopoeia Commission (IPC), an autonomous institution under the Ministry of Health and Family Welfare, Government of India, organized a two-day National Conference on “Quality and Safety of Biosimilars: Strengthening India’s Biopharma SHAKTI Vision” on September 10–11, 2026, at the Centre…...
Novartis India enters exclusive distribution deal with NHPL for retina portfolio
4+ day, 20+ hour ago (167+ words) Novartis India Limited has acquired the exclusive rights to promote and distribute NHPL's retina portfolio across India Novartis India Limited has announced the signing of an exclusive promotion and distribution agreement with Novartis Healthcare Private Limited (NHPL) on September 8, 2026. This…...
Novartis’ pelacarsen trial fails to cut cardiovascular risk
4+ day, 22+ hour ago (54+ words) The pivotal cardiovascular outcomes trial did not meet its primary endpoint FDA moves to boost estradiol patch supply as demand surges Superluminal Medicines raises $60 million to push obesity drug into clinic Novartis’ pelacarsen trial fails to cut cardiovascular risk Indian…...
Lupin gets US FDA nod for Modafinil tablets
1+ week, 1+ day ago (155+ words) Global pharmaceutical major Lupin Limited has received approval from the U.S. Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Modafinil Tablets USP, 100 mg and 200 mg. The approved tablets are bioequivalent to Provigil, the reference listed drug…...
GSK moves toward first Phase III trial of mRNA flu vaccine targeting both HA and NA
1+ week, 3+ day ago (84+ words) Indian Pharma Post GSK moves toward first Phase III trial of mRNA flu vaccine targeting both HA and NA GSK plans to begin a Phase III efficacy trial in September 2026 Chasing Consistency: Centralizing operations data is the key to optimizing…...
AstraZeneca completes Dizal deal for lung cancer drug Zegfrovy
1+ week, 3+ day ago (60+ words) The deal gives AstraZeneca global control of a drug targeting a particularly aggressive form of lung cancer with significant unmet treatment needs Medtronic to invest $700 million in Hong Kong surgical robotics firm Scan.com raises $220 million to expand US medical…...
Osivax and GC Biopharma partner on next-generation flu vaccine
1+ week, 5+ day ago (55+ words) Dr. Rajesh Nair appointed CEO of Park Group of Hospitals India cuts malaria cases and deaths by nearly 80% over a decade IPC launches 12 reference standards to strengthen quality of phytopharma Cipla’s InvaGen plant in New York gets VAI status from…...
Aurobindo Pharma subsidiary launches generic Advair Diskus in US
1+ week, 6+ day ago (207+ words) Lannett company commercialises first product from its inhalation pipeline in two strengths Aurobindo Pharma USA’s wholly owned subsidiary Lannett Company LLC has launched the generic equivalent of Advair Diskus® (fluticasone propionate and salmeterol inhalation powder) in the US market. The…...
Zydus’ Saroglitazar Mg clears key hurdle in global MASH trial
1+ week, 6+ day ago (73+ words) EVIDENCES-X trial met its primary endpoint, with a 26.5% treatment difference in MASH resolution without worsening of fibrosis Dr. Rajesh Nair appointed CEO of Park Group of Hospitals India cuts malaria cases and deaths by nearly 80% over a decade IPC launches…...
TMIV Imaging launches AI-driven CLARION 64/128-slice CT system in India
1+ week, 6+ day ago (250+ words) Time Medical International Ventures (TMIV Imaging), a wholly owned subsidiary of Fischer Medical Ventures Limited, has launched its CLARION 64/128-Slice High-Performance AI-Driven CT System in India at the India Health Expo 2026. The system was formally launched by Dr. Sunil K. Khetrapal,…...